Professor
University of Alabama at Birmingham
Dr. Limdi is professor of Neurology and Epidemiology, Director, Program for Translational Pharmacogenomics and Associate Director Hugh Kaul Personalized Medicine Institute and holds appointments in Nephrology, cardiology and Clinical Pharmacology and Toxicology.
Dr. Limdi started her career as a pharmacist after graduating from Samford University with a Pharm.D (1994). Her observations on variability of drug response fueled her interests in understanding genetic underpinnings of drug response. She continued her training obtaining her MSPH (2005) and PhD in Epidemiology (2007).
Her efforts to recruit and engage African Americans (AA) and medically underserved patients has been vital to her contributions to understanding racial differences in drug response, identifying race-specific variants, reporting on the differential impact of gene variants and comorbidities by race.
Her RESEARCH focuses on clinical and genetic underpinnings of anticoagulant and antiplatelet response (this work has been NIH funded since 2003). She is the PI for NHGRI’s eMERGE grant which aims to harness the power of genomics to predict and prevent risk of common chronic diseases.
Through her work, Dr. Limdi has collaborated extensively including with National and International Consortia and the Food and Drug Administration.
As a clinical pharmacist and chronic disease epidemiologist with 20 years of experience, she brings her breath of expertise to TRAINING AND MENTORSHIP in clinical pharmacy, chronic disease epidemiology, pharmacogenomics to lead research and implementation of genomics in clinical practice.
Dr. Limdi oversees discovery and clinical implementation of pharmacogenomics across the UAB health system and the Alabama genomic Health Initiative
Disclosure information not submitted.
Tuesday, January 11, 2022
8:00 PM – 9:00 PM ET
Wednesday, January 12, 2022
12:00 PM – 1:00 PM ET
.png)